The role of indoleamine 2,3-dioxygenase (IDO) in the pathogenesis of non-alcoholic steatohepatitis (NASH) and atherosclerosis as comorbidities

The role of indoleamine 2,3-dioxygenase (IDO) in the pathogenesis of non-alcoholic steatohepatitis (NASH) and atherosclerosis as comorbidities

Bibliografiset tiedot
Päätekijät:	Arora, A, Tripodi, GL, Kareinen, I, Berg, M, Forteza, MJ, Cole, J, Monaco, C, Ketelhuth, DF
Aineistotyyppi:	Conference item
Kieli:	English
Julkaistu:	Lippincott, Williams & Wilkins 2021

Samankaltaisia teoksia

Genetic deficiency of indoleamine 2,3-dioxygenase aggravates vascular but not liver disease in a nonalcoholic steatohepatitis and atherosclerosis comorbidity model
Tekijä: Arora, A, et al.
Julkaistu: (2022)

The Two Sides of Indoleamine 2,3-Dioxygenase 2 (IDO2)
Tekijä: Chiara Suvieri, et al.
Julkaistu: (2024-11-01)

Manipulation of indoleamine 2,3-dioxygenase (IDO) for clinical transplantation: promises and challenges.
Tekijä: Quan, J, et al.
Julkaistu: (2008)

Manipulation of indoleamine 2,3-dioxygenase (IDO) for clinical transplantation: promises and challenges
Tekijä: Quan, J, et al.
Julkaistu: (2008)

TRYPTOPHAN AND INDOLEAMINE-2,3-DIOXYGENASE (IDO) IN PATHOGENESIS OF IMMUNOSUPPRESSIVE CLINICAL CONDITIONS
Tekijä: V. A. Kozlov, et al.
Julkaistu: (2017-07-01)

Indoleamine 2,3-dioxygenase (IDO): Only an enzyme or a checkpoint controller?
Tekijä: Cemil Bilir, M.D., et al.
Julkaistu: (2017-07-01)

Activation of the Regulatory T-Cell/Indoleamine 2,3-Dioxygenase Axis Reduces Vascular Inflammation and Atherosclerosis in Hyperlipidemic Mice
Tekijä: Maria J. Forteza, et al.
Julkaistu: (2018-05-01)

Indoleamine 2,3-Dioxygenase (IDO) Expression Is an Independent Prognostic Marker in Esophageal Adenocarcinoma
Tekijä: Heike Loeser, et al.
Julkaistu: (2020-01-01)

Indoleamine 2,3 Dioxygenase (IDO) Expression and Activity in Relapsing-Remitting Multiple Sclerosis.
Tekijä: Roberta Mancuso, et al.
Julkaistu: (2015-01-01)

The indoleamine-2,3-dioxygenase (IDO) inhibitor 1-methyl-D-tryptophan upregulates IDO1 in human cancer cells.
Tekijä: Christiane A Opitz, et al.
Julkaistu: (2011-01-01)

Tolerance induction by monoclonal CD3 antibodies is dependent on indoleamine 2,3 dioxygenase (IDO)
Tekijä: Kuhn, C, et al.
Julkaistu: (2012)

Inhibition of Indoleamine-2,3-dioxygenase (IDO) in Glioblastoma Cells by Oncolytic Herpes Simplex Virus
Tekijä: Bonnie Reinhart, et al.
Julkaistu: (2012-01-01)

Activity of Indoleamine 2, 3 Dioxygenase (IDO) in Type 2 Diabetes Mellitus Patients in Pakistan
Tekijä: Syed Harris Hussain
Julkaistu: (2017-06-01)

Association of Indoleamine 2,3-dioxygenase (ido) activity with outcome after cardiac surgery in adult patients
Tekijä: Stieger, A, et al.
Julkaistu: (2024)

Association of Indoleamine 2,3-Dioxygenase (IDO) Activity with Outcome after Cardiac Surgery in Adult Patients
Tekijä: Andrea Stieger, et al.
Julkaistu: (2024-06-01)

Indoleamine 2,3-Dioxygenase (IDO) Activity: A Perspective Biomarker for Laboratory Determination in Tumor Immunotherapy
Tekijä: Pengbo Yang, et al.
Julkaistu: (2023-07-01)

Structure-based optimization of type III indoleamine 2,3-dioxygenase 1 (IDO1) inhibitors
Tekijä: Ute F. Röhrig, et al.
Julkaistu: (2022-12-01)

Aging-associated increase in indoleamine 2,3-dioxygenase (IDO) activity appears to be unrelated to the transcription of the IDO1 or IDO2 genes in peripheral blood mononuclear cells
Tekijä: Jylhä Marja, et al.
Julkaistu: (2011-10-01)

Activities of plasma indoleamine-2, 3-dioxygenase (IDO) enzyme in Nigerian patients with lung diseases: basis for tryptophan supplementation or IDO inhibitor use
Tekijä: Ganiyu Olatunbosun Arinola, et al.
Julkaistu: (2023-01-01)

Immunohistochemical Features of Indoleamine 2,3-Dioxygenase (IDO) in Various Types of Lymphoma: A Single Center Experience
Tekijä: Mee-seon Kim, et al.
Julkaistu: (2020-05-01)

Indoleamine 2,3-dioxygenase 1 (IDO1) activity correlates with immune system abnormalities in multiple myeloma
Tekijä: Bonanno Giuseppina, et al.
Julkaistu: (2012-12-01)

Indoleamine 2,3-dioxygenase 1 (ido1) is involved in the control of mouse caput epididymis immune environment.
Tekijä: Aicha Jrad-Lamine, et al.
Julkaistu: (2013-01-01)

Respiratory syncytial virus replication induces Indoleamine 2,3-dioxygenase (IDO) activation in human dendritic cells
Tekijä: Ajamian Farnam, et al.
Julkaistu: (2010-11-01)

Deletion of indoleamine 2,3 dioxygenase (Ido)1 but not Ido2 exacerbates disease symptoms of MOG35-55-induced experimental autoimmune encephalomyelitis
Tekijä: Lisa A. Wetzel, et al.
Julkaistu: (2020-08-01)

Increased Indoleamine 2,3-Dioxygenase 1 (IDO-1) Activity and Inflammatory Responses during Chikungunya Virus Infection
Tekijä: Thiara Manuele Alves de Souza, et al.
Julkaistu: (2022-04-01)

Progesterone decreased indoleamine 2,3-dioxygenase 1(IDO1) expression in early pregnancy chorionic villi and decidua
Tekijä: Minyan Yang, et al.
Julkaistu: (2021-04-01)

Discovery of Indoleamine 2,3-Dioxygenase 1 (IDO-1) Inhibitors Based on Ortho-Naphthaquinone-Containing Natural Product
Tekijä: Hongchuan Zhao, et al.
Julkaistu: (2019-03-01)

Interferon-γ regulates the proliferation and differentiation of mesenchymal stem cells via activation of indoleamine 2,3 dioxygenase (IDO).
Tekijä: Juliana Croitoru-Lamoury, et al.
Julkaistu: (2011-01-01)

Updates in the Clinical Development of Epacadostat and Other Indoleamine 2,3-Dioxygenase 1 Inhibitors (IDO1) for Human Cancers
Tekijä: Takefumi Komiya, et al.
Julkaistu: (2018-10-01)

Synthesis and Molecular Modeling Studies of N′-Hydroxyindazolecarboximidamides as Novel Indoleamine 2,3-Dioxygenase 1 (IDO1) Inhibitors
Tekijä: Dong-Ho Lee, et al.
Julkaistu: (2017-11-01)

Indoleamine 2,3-dioxygenase in endometriosis
Tekijä: Hui-Li Yang, et al.
Julkaistu: (2019-01-01)

Inhibitory effect of human indoleamine 2,3-dioxygenase 1 (hIDO1) by kazinols of 1,3-diphenylpropane derivatives
Tekijä: Taehoon Oh, et al.
Julkaistu: (2024-09-01)

3D-QSAR Study of Indol-2-yl Ethanones Derivatives as Novel Indoleamine 2,3-Dioxygenase (IDO) Inhibitors
Tekijä: Kamlendra S. Bhadoriya, et al.
Julkaistu: (2012-01-01)

Preferential expression of CD200 and Indoleamine 2, 3-dioxygenase-1 (IDO-1) in Acute Myeloid Leukemia Patients with Relapse
Tekijä: Ali Memarian, et al.
Julkaistu: (2015-12-01)

Correction: Inhibitory effect of human indoleamine 2,3-dioxygenase 1 (hIDO1) by kazinols of 1,3-diphenylpropane derivatives
Tekijä: Taehoon Oh, et al.
Julkaistu: (2024-09-01)

Contribution of indoleamine 2,3-dioxygenase in preeclampsia
Tekijä: Mona F.M El-Karn, et al.
Julkaistu: (2016-01-01)

Targeting Indoleamine Dioxygenase and Tryptophan Dioxygenase in Cancer Immunotherapy: Clinical Progress and Challenges
Tekijä: Peng X, et al.
Julkaistu: (2022-08-01)

Editorial: Targeting Indoleamine 2,3-dioxygenases and Tryptophan Dioxygenase for Cancer Immunotherapy
Tekijä: Lieve Brochez, et al.
Julkaistu: (2021-12-01)

Indoleamine-2,3-dioxygenase (IDO) Mediates the Suppression of T Cells by IFN-γ Primed Mesenchymal Stromal Cells in the Treatment of Psoriasis-Like Inflammation
Tekijä: Weidong Zhu, et al.
Julkaistu: (2024-12-01)

Systemic treatment with CpG-B after sublethal rickettsial infection induces mouse death through indoleamine 2,3-dioxygenase (IDO).
Tekijä: Lijun Xin, et al.
Julkaistu: (2012-01-01)